Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause Article

sustainable development goals

authors

Archer, David F.

publication date

2016

webpage

Web of Science

published in

MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY Journal

keywords

Dehydroepiandrosterone
Dryness
Dyspareunia
Genitourinary syndrome of menopause
Intracrinology
Prasterone
Vulvovaginal atrophy

start page

243

end page

256

volume

23

issue

3